venBio Partners’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

venBio Partners’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-383,390	Closed	-$4.71M	–	7
2022 Q4	$4.71M	Sell	383,390 -1,478,866	-79%	-$35.2M	1.46%	6
2022 Q3	$61.1M	Sell	1,862,256 -282,779	-13%	-$7.99M	14.14%	3
2022 Q2	$40.4M	Buy	2,145,035 +164,329	+8%	+$3.15M	11.51%	5
2022 Q1	$34.7M	Buy	+1,980,706	New	+$40.6M	7.7%	5

venBio Partners's CINC Position: Q1 2023 in Review

venBio Partners sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 383,390 shares — an estimated $4.71M sold.

venBio Partners first reported a position in CINC in Q1 2022 and held it in 4 quarters. The position peaked at $61.1M in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

venBio Partners reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
venBio Partners sold 383,390 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $4.71M.
venBio Partners first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
venBio Partners's CinCor Pharma, Inc. Common Stock position peaked at $61.1M in Q3 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on venBio Partners's 13F filing for Q1 2023, filed 15 May 2023.